Take a look at this month’s industry headlines including news on Sanofi’s Dengvaxia® vaccine from the USA and the Philippines, clinical trial results for RSV vaccines and HIV injectables and new acquisitions for Merck.
Browsing: Clinical > Antimicrobial Resistance
Economist, Lord Jim O’Neill, has suggested that nationalized or state-run drug companies could be the answer to the lack of investment in antibiotic development.
An international study has compared the number of antibiotic resistance genes in water treatment plants across European countries, discovering that this correlates with the number of resistant bacteria in patient samples and antibiotic consumption across the region.
New research from the Stevens Institute of Technology has developed a microgel coating for implanted medical devices that can release micro-doses of antibiotics on bacterial contact, potentially combatting infection.
Could the development of products that produce a constant level of exogenous Reactive Oxygen® be beneficial in preventing and treating polymicrobial wound infections? Discover the potential of this avenue for multi-drug resistant organisms and more in our latest opinion piece.
The World Health Organization has released a new Technical Note updating countries worldwide on optimal methods and diagnostic techniques to improve antimicrobial resistance surveillance.
Researchers from Newcastle University have reported the presence of antibiotic-resistant genes in one of the most remote, ‘unspoiled’ regions on Earth.
The UK government has published a 20-year vision and a 5-year national action plan for how the UK will contribute to controlling and containing antimicrobial resistance by 2040.
What effects can intrapartum antimicrobial use have on the neonatal microbiome development? And could they impact in long-term health?
A study published in the BMJ, involving more than 19 million patients, has concluded that 23.9% of antibiotic prescriptions given to outpatients in the US are inappropriate.